Source: Medicines & Healthcare Products Regulatory Agency (GB) Revision Year: 2011 Publisher: Merck Sharp & Dohme Limited Hertford Road, Hoddesdon Hertfordshire EN11 9BU UK
FOSAMAX 10 mg Tablets.
| Pharmaceutical Form |
|---|
|
Tablets. Oval white tablets marked with ‘936’ on one side, and plain on the other. |
Each tablet contains 13.05 mg of alendronate sodium, which is the molar equivalent to 10 mg of alendronic acid.
Excipients:
Each tablet contains 103.95 mg lactose anhydrous.
For a full list of excipients see section 6.1
| Active Ingredient |
|---|
|
Alendronic acid is a bisphosphonate that inhibits osteoclastic bone resorption with no direct effect on bone formation. The bone formed during treatment with alendronic acid is of normal quality. |
| List of Excipients |
|---|
|
10 mg tablets: Microcrystalline cellulose |
Blisters of opaque white PVC lidded with aluminium foil.
Pack size: 28 tablets.
Merck Sharp & Dohme Limited
Hertford Road, Hoddesdon
Hertfordshire
EN11 9BU
UK
10 mg tablets: PL 0025/0326
10 mg tablets: 28 July 1995/ 3 June 2008
| Drug | Countries | |
|---|---|---|
| FOSAMAX | Austria, Brazil, Canada, Germany, Spain, France, Hong Kong, Croatia, Ireland, Italy, Mexico, Netherlands, New Zealand, Romania, Singapore, Turkey, United Kingdom, United States, South Africa |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.